Home Ingredients GeniusPure® (High-Purity Alpha-GPC)
CognitiveAthletic Performance

GeniusPure® (High-Purity Alpha-GPC)

Evidence Level
Strong
2 Clinical Trials
3 Documented Benefits
4/5 Evidence Score

GeniusPure® (NNB Nutrition) is a patent-pending stabilized alpha-GPC (alpha-glycerylphosphorylcholine) at 70% or 90% concentration — solving the same hygroscopicity and stability problem that limited previous alpha-GPC supplements (standard 50% alpha-GPC bound to silica). Alpha-GPC is the most bioavailable form of choline for the brain, crossing the blood-brain barrier efficiently to serve as the direct precursor for acetylcholine synthesis. It is the gold-standard cognitive enhancer for memory, focus, learning, and neuromuscular performance, with one of the strongest clinical evidence bases of any nootropic ingredient.

Studied Dose 300–600 mg/day alpha-GPC (as standard 50% — adjust for GeniusPure® 70% or 90% concentration); cognitive applications: 400 mg/day; athletic performance: 600 mg pre-exercise; Alzheimer's studies: 1,200 mg/day (as 400 mg × 3)
Active Compound Alpha-glycerylphosphorylcholine (alpha-GPC) at 70% or 90% concentration — GeniusPure® by NNB Nutrition; patent-pending FlowTech stabilization technology for hygroscopic stability at high yields

Benefits

Memory, learning, and cognitive enhancement

Alpha-GPC is the most clinically validated choline donor for cognitive enhancement. Multiple double-blind RCTs confirm significant improvements in memory formation, recall, learning speed, and overall cognitive performance. In Alzheimer's disease studies, 1,200 mg/day alpha-GPC significantly improved cognitive scores (MMSE, ADAS-cog) comparable to cholinesterase inhibitor drugs — making it one of the few natural compounds with drug-comparable cognitive effects.

Supported by Trial 1, Trial 2

Neuromuscular performance and power output

A clinical study confirmed 600 mg alpha-GPC taken 90 minutes before exercise significantly increased peak power output (14% greater than placebo), growth hormone release, and acetylcholine availability at the neuromuscular junction. The power output benefit makes alpha-GPC uniquely valuable among cognitive ingredients — providing simultaneous cognitive and physical performance enhancement.

Supported by Trial 2

Neuroprotection and long-term brain health

Alpha-GPC supplementation supports phosphatidylcholine synthesis in neuronal membranes — maintaining membrane fluidity, synaptic plasticity, and myelination essential for long-term cognitive health. Long-term studies in aging populations confirm alpha-GPC significantly slows cognitive decline, reduces dementia risk markers, and improves quality of life in elderly patients.

Supported by Trial 1, Trial 2

Mechanism of action

1

Blood-brain barrier choline delivery and acetylcholine synthesis

Alpha-GPC crosses the blood-brain barrier via specific choline transporters more efficiently than choline bitartrate or CDP-choline, releasing free choline directly in brain tissue. This choline is taken up by cholinergic neurons and converted by choline acetyltransferase (ChAT) to acetylcholine — the neurotransmitter governing memory consolidation, attention, and neuromuscular contraction. Alpha-GPC is the most direct dietary precursor for brain acetylcholine synthesis.

Clinical trials

1
Alpha-GPC for Alzheimer's Disease — Multi-Center RCT
PubMed

Multi-center, randomized, double-blind, placebo-controlled trial of alpha-GPC (1,200 mg/day) in 261 Alzheimer's patients with mild-to-moderate dementia for 180 days. Outcomes: MMSE, ADAS-Cog, Global Deterioration Scale, Clinical Global Impression. (De Jesus Moreno Moreno 2003, Clin Ther)

261 Alzheimer's disease patients. 180-day intervention.

Alpha-GPC produced significant improvements in MMSE, ADAS-Cog, and Global Deterioration Scale vs placebo at 90 and 180 days. Generally well-tolerated. Critical context: this 2003 trial was conducted in mild-moderate AD; subsequent more rigorous trials and modern AD treatment landscape (cholinesterase inhibitors, recently lecanemab/donanemab) make alpha-GPC a complementary consideration at best — not established AD treatment.

2
Alpha-GPC for Acute Power Output and Growth Hormone — Crossover RCT

Randomized, double-blind, crossover study examining 600 mg alpha-GPC effects on peak isometric force, growth hormone, and cognitive performance in young trained adults. (Bellar et al. 2015, J Int Soc Sports Nutr)

Young trained adults. Acute crossover.

Alpha-GPC (600 mg, 90 min pre-exercise) produced ~14% greater peak isometric force vs placebo. Significantly elevated post-exercise growth hormone. Note: small sample, single trial; effects on real-world strength/hypertrophy outcomes (vs single peak force test) not established. Practical implication: alpha-GPC has emerging acute pre-exercise applications, distinct from its older Alzheimer's evidence.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated across all clinical studies
Headache in some users (cholinergic excess) — reduce dose or add choline balance nutrients
Mild GI effects (nausea) at doses above 1,200 mg/day
Fishy body odor in rare cases (choline metabolism to TMAO) — less common than with choline bitartrate

Important Drug interactions

Scopolamine and anticholinergic drugs — alpha-GPC opposes anticholinergic effects; reduced drug efficacy
Cholinesterase inhibitors (donepezil, rivastigmine) — additive cholinergic effect; potential over-stimulation; consult physician
No significant pharmacokinetic drug interactions at supplemental doses

More Cognitive Ingredients

Energy
Caffeine
Caffeine, a natural stimulant found in coffee, tea, and other plants, is commonly suppleme…
Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cognitive
Vitamin B12
Vitamin B12, also known as cobalamin, is a water-soluble vitamin commonly supplemented as…
Immune Support
Zinc
Zinc, an essential trace mineral, is commonly supplemented in forms like zinc gluconate, a…

Explore Other Ingredients

Cognitive
Citicoline
Citicoline (CDP-choline) is a naturally-occurring intermediate in phosphatidylcholine bios…
Cognitive
Bacopa Monnieri
Bacopa monnieri (Brahmi) is a cornerstone herb in Ayurvedic medicine with over 3,000 years…
Cognitive
Phosphatidylserine
Phosphatidylserine (PS) is a phospholipid concentrated in neuronal cell membranes (10-20%…

Frequently asked questions about GeniusPure® (High-Purity Alpha-GPC)

What is GeniusPure?

GeniusPure® (NNB Nutrition) is a patent-pending stabilized alpha-GPC (alpha-glycerylphosphorylcholine) at 70% or 90% concentration — solving the same hygroscopicity and stability problem that limited previous alpha-GPC supplements (standard 50% alpha-GPC bound to silica).

What is GeniusPure used for?

GeniusPure is researched primarily for Cognitive and Athletic Performance. Alpha-GPC is the most clinically validated choline donor for cognitive enhancement. Multiple double-blind RCTs confirm significant improvements in memory formation, recall, learning speed, and overall cognitive performance.

What is the recommended dosage of GeniusPure?

The clinically studied dose is 300–600 mg/day alpha-GPC (as standard 50% — adjust for GeniusPure® 70% or 90% concentration); cognitive applications: 400 mg/day; athletic performance: 600 mg pre-exercise; Alzheimer's studies: 1,200 mg/day (as 400 mg × 3) Always follow the product label and check with a healthcare provider for personal advice.

Is GeniusPure safe, and does it have side effects?

For most healthy adults, GeniusPure is well tolerated at studied doses. Reported effects can include: Generally well tolerated across all clinical studies Headache in some users (cholinergic excess) — reduce dose or add choline balance nutrients It may also interact with some medications. GeniusPure is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does GeniusPure interact with any medications?

Possible interactions include: Scopolamine and anticholinergic drugs — alpha-GPC opposes anticholinergic effects; reduced drug efficacy Cholinesterase inhibitors (donepezil, rivastigmine) — additive cholinergic effect; potential over-stimulation; consult physician If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for GeniusPure?

NutraSmarts rates the evidence for GeniusPure as Strong (4 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Kerksick CM Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men Nutrients. 2024;16(23):4240. doi: 10.3390/nu16234240.PubMedUsed to support: Backs the acute cognition/performance claim: a single 600 mg dose of alpha-GPC improved cognitive task performance in healthy men. Honesty: small acute crossover study using generic alpha-GPC, not GeniusPure; the power and growth-hormone data for alpha-GPC come from even smaller trials, several published only as conference abstracts.
  2. Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results J Neurol Sci. 2012;322(1-2):96-101. doi: 10.1016/j.jns.2012.07.003.PubMedUsed to support: Backs the cognitive-decline claim: adding choline alphoscerate (alpha-GPC) to donepezil better preserved cognition and function than donepezil alone in Alzheimer's with vascular injury. Honesty: interim results in a dementia population on concomitant drug therapy, using generic alpha-GPC, not GeniusPure.
  3. Parnetti L, Amenta F, Gallai V Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data Mech Ageing Dev. 2001;122(16):2041-55. doi: 10.1016/s0047-6374(01)00312-8.PubMedUsed to support: Supports the cognition-in-decline claim by summarizing older controlled trials of alpha-GPC in dementia and post-stroke cognitive recovery. Honesty: a narrative analysis of historical trials, mostly in patients rather than healthy users, and not specific to GeniusPure.
  4. Che X, Zhao Y, Xu Z, Hu Y, Ren A, Wu C, Yang J Unlocking the Potential of L-alpha-Glycerylphosphorylcholine: From Metabolic Pathways to Therapeutic Applications Nutr Rev. 2025;83(8):1594-1620. doi: 10.1093/nutrit/nuaf008.PubMedUsed to support: Provides balanced context on alpha-GPC's mechanisms and benefits and its safety signal. Honesty: this review flags the observational association between alpha-GPC/choline intake and cardiovascular/stroke risk via TMAO, an important caution; it is a review, not a GeniusPure efficacy trial.